Skip to main content

Digital Health Trailblazers: Top Visionary Leaders To Watch in 2025. Digital Version

Page 1


Providing ABA 1-to-1 therapy in your home

Offering social skills training and groups

Supplying community-based training

Supplying prevocational training at an early age

Providing parents and family members with training, too

EDITOR’S LETTER

Innovating for a Healthier Tomorrow

DearReaders,

Wearelivingthroughthemostprofoundtransformationinhealthcarehistory,adigitalfrontierwheredata, artificialintelligence,andhuman-centricdesignareconvergingtoredefineourrelationshipwithwellness.This revolutionisn’thappeningonitsown;itisbeingdrivenbybrilliant,determinedindividualswhoseetechnology notasanend,butasameanstoamorecompassionateandefficientsystemofcare.Inthisspecialissue, “DigitalHealthTrailblazers:TopVisionaryLeaderstoWatchin2025,”wecelebratethesearchitectsof change—theleaderswhoarecodingahealthierfutureforusall.

Ourcoverstoryfeaturesonesuchvisionary,MpumeleloTembe,Co-FounderofPerkily.io.Heisaskinga simplebutrevolutionaryquestion:whatifwerewardedpeopleforbeinghealthy?Withauniquebackground thatfusesthelogicofsupplychainswiththeempathyofcustomersuccess,Mpumeleloistranslatingthe sophisticatedlanguageofuserengagementintotheworldofhealthcare.Hiscompany,Perkily,isabridge designedtosolveatrioofsystemicproblems:access,engagement,andexperience.BycreatinganAI-powered platformwherepatientsearntangiblerewardsforhealthyactions,Perkilymakesproactivewellnessmore accessibleandengaging.Itisamission-drivenventurebornfromadesiretousetechnologytomakehealthcare morehuman,strengtheningthevitalconnectionbetweenpatientsandproviders.

Mpumelelo’sdrivetosolvefundamentalhealthcarechallengesisaqualitysharedbyallourfeatured trailblazers.WearealsoproudtospotlighttheremarkableachievementsofMenzoHavenga,Presidentand CEOofBataviaBiosciences;MortenOlesen,afoundingpartneratCIMS;JenniferPinasco,ChiefExecutive OfficeratYosemitePathology|PrecisionPathology;andKevinGoodwin,CEOofEchoNous.Eachofthese leadersispioneeringchangeintheirrespectivefields,frombiopharmaceuticalstodiagnosticsandconsulting.

Theirstoriesareapowerfulreminderthatbehindeveryalgorithmanddatapointisapersondedicatedto improvinghumanlives.Weinviteyoutoexploretheirjourneysanddiscoverthefutureofhealththeyare buildingtoday

Cover Story

T E N T S

Mpumelelo

Tembe

In the often-impersonal world of healthcare, Mpumelelo Tembe is betting on a simple, revolutionary idea: what if we rewarded people for being healthy? His company, Perkily, is a sophisticated, deeply human attempt to rewire our relationship with wellness, one point, one reminder, and one real connection at a time.

Thereisalanguagethatunderpinsthemodernworld,a grammarofengagementwrittenbye-commercegiantsand SaaSpioneers.It’sthelanguageofloyaltypoints,of personalizedjourneys,ofautomatednudgesthatanticipate ourneedsbeforewedo. isfluentinthis MpumeleloTembe language.Foroversevenyears,hemastereditsdialectsin customersuccess,buildingsystemsthatmadeusersfeel seenandvalued.Butthenhedecidedtotranslateitintoa languageithadseldomspokenfluently: .healthcare

TheresultisPerkily,aJohannesburg-baseddigitalhealth companyheco-foundedwithDariusNaidooin2024.To callitaplatformfeelstoosterile.It’smorelikean ecosystem,acarefullyconstructedenvironmentwherethe transactionalnatureofaclinicvisitbeginstofeellikea relationship.Tembe,withabackgroundthatfusesthelogic ofsupplychainswiththeempathyofcustomersuccess,saw agapinthesystem.Hesawpatientsfallingthroughcracks, providersstrugglingtoconnect,andauniversalhuman need,thepursuitofhealth,lackingtheveryengagement strategiesthatselluseverythingfromcoffeetocloud storage.

MeetingTembeistounderstandthatthisisnotjusta marketopportunityforhim;itisamission.Hespeaksof “systemsthinking” “lifecyclemapping” and withthe samepassionheusestodescribemakinghealthcare “more human.” Inhisvision,technologyisnotawallthatfurther separatesdoctorsandpatients,butabridge.Perkilyisthat bridge,builtwiththeprecisionofalogisticianandtheheart ofastrategistwhobelievesthatthebestsystemsare designednotjustforusers,butforpeople.

FromSystemsThinkingtoHuman-CenteredHealth

MpumeleloTembe’sjourneystartedwithafascinationfor howthingsconnect.HisB.AdmininSupplyChain& PublicAdministrationfromtheUniversityofKwaZuluNatal,followedbyanHonorsB.CominLogistics,gavehim aprofoundunderstandingofsystems—howtheyflow, wheretheybreak,andhowtomakethemmoreefficient. Thisfoundation,seeminglydistantfromhealthcare,would becomehissecretweapon.

Stay focused, stay human, and don’t be afraid to build slow if you're building something that lasts “ ”

Hisprofessionallifewasspentinthetrenchesofcustomer engagement.Foroversevenyears,heledclientsuccess teamsacrossSaaS,technology,andservice-driven industries,withafootprintintheUK,US,andAfrican markets.Hebuiltcustomersuccessfunctionsfromthe groundup,designedonboardingjourneysthatfeltintuitive, andturnedmountainsofuserfeedbackintoactionable improvements. hesays, “I really found my space,” “helping startups and growth-stage teams design onboarding journeys, improve retention, and turn feedback into action.”

Thetransitiontodigitalhealthwasnotanaccident;itwasa choice,adeliberatepivot. “I’ve always believed in using technology to solve real problems,” “and Tembeexplains, healthcare, especially in Africa, is filled with opportunities to do just that.” TheideaforPerkilywastheconfluenceof histwoworlds.Hesawachancetoapplythesophisticated mechanicsofcustomerloyaltyandautomationtooneofthe mostfundamentalhumanneeds. “It wasn’t just about launching another product,” “It was about heinsists. creating a real-world impact.” Thisdrivedefineshis leadership:usingtheprovenprinciplesofcustomersuccess toengineerbetter,morecompassionatesystemsofcare.

ThePerkilyPrescription:SolvingforAccess, Engagement,andExperience

TheoriginofPerkilyliesinadiagnosisofthehealthcare systemitself.Tembeandhisteam,includingkey contributors and ,identifieda DariusNaidoo AneleXaba trioofinterconnectedproblemsthatplaguethepatient experience.

Thefirstwas toomanypeoplefacerealbarriers, Access: whethercost,distance,orasimplelackofinformation, whentryingtogetcare.ThesecondwasEngagement: clinicsandpharmaciesstruggledtokeeptheirpatients comingback,toencourageproactive,preventativehealthin amodelbuiltaroundreactivetreatment.Thethirdwas Experience:thevitalrelationshipbetweenadoctoranda patienthadoftenbecometransactional,rushed,and impersonal.

“Perkily was born out of a desire to make healthcare more accessible, more engaging, and more human,” Tembestates. Itwasdesignedasthebridgetospanthatgap.Theplatform isanelegantsolutionthattacklesallthreeissues simultaneously.Itmakesaccessingcaremorerewarding,it recognizesandincentivizeshealthybehavior,andituses technologytostrengthen,notsupplant,thehuman connectionbetweenaproviderandtheirpatient.

Cover Story

ThecoreofPerkilyisaloyalty-driven,AI-powered engagementplatform.It’saB2Bserviceofferedtoclinics, pharmacies,andwellnessbrands,butitsfocusissquarely ontheend-user:thepatient.Thesystemisbuiltonthree pillars.ThefirstisPatientLoyalty&Rewards.Patients earnpointsfordoingtheverythingsthatkeepthem healthy—attendingappointments,refillingmedications,or completinghealthscreenings.Thesepointsarenotabstract; theycanberedeemedforcuratedwellnessproductsand services,turninghealthyactionsintotangiblerewards.

ThesecondpillarisanAI-poweredassistantnamed FlemingAI.This24/7toolprovidespatientswith everythingfromsymptomcheckstomedicationqueriesand preventativehealthtips,empoweringthemwithinformation whilereducingtheadministrativeloadonfrontlinestaff.

ThethirdpillarisOperationalIntelligence& Automation.Perkilyautomatesappointmentreminders, sendsfollow-upmessages,andprovidesreal-time dashboardsthathelpreduceno-showsandstreamline workflows.AClinicalNotesModulefurthersupports providerswithsmartdocumentation,voice-to-text capabilities,automatedICD-10coding,andAI-generated summaries,savingclinicianswhatTembeestimatescanbe 30-40%oftheirdocumentationtime.Inessence,Perkily helpsprovidersdeliverbetter,moreefficientcarewhile buildinglasting,loyalty-basedrelationships.

E-CommerceTactics,ClinicalResults

ThegeniusofPerkilyisinitsadaptationofstrategieshoned inthecutthroatworldofonlineretail. “We’ve adapted proven e-commerce strategies—like rewards, automation, and personalized messaging—to strengthen patient engagement in healthcare,” Tembeexplains.Bycreatinga systemwherepatientsarerewardedfortheirproactive participation,Perkilyfundamentallyshiftsthedynamic frompassiverecipienttoactivepartnerinone'sownhealth journey

Theresultshavebeenstriking.PracticesusingPerkilyhave reporteduptoa25%increaseinreturnvisitswithinjust90 days.Appointmentattendanceimproves.Patientsatisfaction rises.Theautomatedremindersandfollow-upsarenotjust spam;withopenratesofover35%andclick-throughrateson post-visitmessagesbetween20-30%,it’sclearthe communicationisseenasvaluable.Thisisthee-commerce playbooktranslatedintoaclinicalsetting,andit’sworking.

However,leveragingadvancedtechnologyinasectoras sensitiveashealthcarerequiresadeepcommitmenttoethics. Tembeisresoluteonthispoint.“Perkilyisbuiltona foundationoftrust,accessibility,andempathy,”heasserts. Dataprivacyisparamount,withfullcompliancewithPOPIA, GDPR,andHIPAA,enforcedthroughsecureencryptionand azero-trustarchitecture.Toensureequity,theplatformis mobile-first,designedtobeaccessibleacrossincomelevels andinlow-dataenvironments,withgoalstosupportlocal languages.Thedesignphilosophyisstaunchlyhumancentered,ensuringthatFlemingAIanditsautomationtools supportmeaningfulconnections,ratherthanreplacingthem.

FromJohannesburgtotheWorld:AGlobalStrategy

WhilePerkily’sheadquartersareinJohannesburgandits platformwasdesignedwithglobalscalabilityinmind,South Africahasservedasthecrucialinitialtestbed. “South Africa has been invaluable,” Tembenotes,describingitsdiversityin languages,healthcaremodels,andlevelsofaccessasthe perfectenvironmenttorefinetheirapproach.Theyhave focusedonmobile-firstaccessibilityandintegrating culturallyrelevantrewardsandengagement.

ThecompanyalreadyhasactivepilotsinSouthAfrica, Botswana,andKenya,withplansforexpansionintothe UAE,Australia,Singapore,Canada,andtheUS.Tembe’s approachtothisgrowthismethodicalandrespectfuloflocal nuances. “Our goal is not to copy-paste, but to co-create solutions with local partners that reflect the cultural and operational realities of each market we enter.” Thismeans adaptingeverythingfromthedesignandlanguagetothe rewardstructuresandregulatoryrequirements.Itisa‘glocal’ strategy—globallyconceived,locallyexecuted.

Success,forTembe,isnotjustaboutuseracquisitionor revenue.It’samulti-facetedmetricthatblendsharddatawith humanfeedback.Theytrackengagementmetricslikereturn visitratesandrewardredemptionfrequency Theymonitor platformusageacrossdifferentdevicesandregionstoensure theyaremeetingtheiraccessibilitygoals.Andcrucially,they prioritizepatient-reportedoutcomesthroughin-appsurveys

andNPSscores. “Ultimately, success means patients are not only returning—but engaging meaningfully with their care,” hesays.

BuildingwithPurposeUnderPressure

Thejourney,likeanystartupstory,hasbeenfraught withchallenges. “One of the biggest has been building a powerful, scalable platform like Perkily with limited financial resources,” Tembeadmits.Intheearlydays, withoutlargebudgets,theteamhadtoberuthlessly intentional,focusingonlyoncorefeaturesandrelying onstrongpartnerships.Thisconstraintbecamea strength,forcingthemtostayintimatelyconnectedto theirusersandvalidateeverystepwithrealfeedback.

Anothersignificanthurdlewasconvincinghealthcare providers,manyalreadystretchedthin,toadoptanew digitaltool. herecalls.Thekey “Many were hesitant,” toovercomingthiswastolistenfirst.Theysimplified theonboardingprocessandfocusedondemonstrating immediatevalue—howPerkilycouldsavetimeand retainpatients,notaddcomplexity

Theseexperiencesforgedhisleadershipstyle. “These challenges taught me how to lead with empathy, stay agile under pressure, and build for both impact and sustainability—even without perfect conditions.” Itis thisresiliencethathasbeenmostrewarding.Seeinga clinictransitionfromskepticismtoadvocacy, witnessingapatientreturnbecausetheyfeel valued—that,forTembe,isthevalidationoftheentire mission.

Lookingtothefuture,Perkilyaimstobecomethe essentialengagementlayerforeverydayhealthcare.A medicalbillingandclaimsintegrationisslatedforQ4 2025,agame-changerthatwillallowclinicsto processclaimsseamlessly Theyaredeveloping integrationswithpharmaceuticalpartnersforsmarter prescriptionworkflowsandexpandingtheirrewards marketplacetoincludewellness,fitness,andlifestyle brands.

Whentheworkgetsintense,Tembefindshisbalance. Hespendsgroundingtimewithfamilyandfriends. Foranadrenalinereset,heturnstogo-karting. “There’s something about the speed, focus, and adrenaline that resets my energy,” helaughs.Andlike many,hefindsescapeindivingdeepintoagoodTV series.

Hisfinalmessageisoneofpatient persistence. “If there’s one thing I’ve learned, it's that building something meaningful takes time—and showing up consistently matters more than getting everything perfect from day one,” “Stay focused, stay human, hereflects. and don’t be afraid to build slowly if you’re building something that lasts.” Itisa principlethatperfectlycapturestheessenceof bothMpumeleloTembeandthecompanyhe isbuilding:asteady,intentional,anddeeply humanefforttohealthesystemitself.

“ For me, it’s always about people rst the tech, the growth, the results… all of that should serve real human needs

Live with Purpose

A Life With PURPOSE is a LIFE FULFILLED.

Skilled Nursing

Rehabilitation Services

Assisted Living

Dialysis

Home Care

Jennifer Pinasco Building a Different Kind of Healthcare Empire

JenniferPinascocarriesadistinctdefinitionof success.Mostleadersmeasureitinfinancial growthalone.Pinasco,however,beginswith questionsthatprobedeeper:“Didwecompromise anythingtogethere?Whodidwehelp?Howdidwe respondtofailures?Whatculturehavewecreatedbyour behavior?Haveweprovidedsomethingofvalue, somethingneeded?Howdidwetreatpeople?Whatdid welearn?”Sheassertsthatthetruecoreofany organization’sstrength,itsstability,anditslastingimpact, liesinthegoodnessoftheanswerstothesevery questions.

PinascoleadsYosemitePathology|PrecisionPathology asitsChiefExecutiveOfficer.Thecompanystandsas thelargestcollaborativephysician-ownedpracticein NorthernCalifornia,withanadvancedanatomic pathologyandmolecularlaboratory.Forover70years,it hasprovidedcomprehensive,high-qualitydiagnostics, workingwithphysicians,surgerycenters,clinical laboratories,andhospitalstoimprovepatientcare. Pinascohasoverseenaperiodofremarkableexpansion, provingthatgrowth,whenexecutedwithclearprinciples, canservealargerpurpose.

ACareerRootedinService

Pinascoalwaysheldapassionforpathologyandadrive tohelppeople.Shepursuedacademictraining, completingaBachelorofScienceinBusiness AdministrationandaMasterinHealthcare AdministrationfromtheUniversityofPhoenix.Before joiningYosemitePathology,sheworkedinanInternal Medicinepractice,initiallyonapathtobecominganurse. There,shebegantoseeherselfasanambassador, bridgingthegapbetweenpatientsneedingcareandthe physiciansprovidingit.Shewantedtocreatebalance betweenthesetwosidesofthehealthcarespectrum.In 1996,shejoinedYosemitePathology’sRevenueCycle Management(RCM)Team.Shecombinedherskillsand academicknowledge,steadilymovingupthroughthe ranks,eventuallybecomingCEO.

“ChallengeAccepted”:OvercomingRoadblocks

Pinascofacedsignificantchallengesinherearlycareer Theseexperiencesforgedherpersonalmantra:“Challenge Accepted.”Shebegantobuildateamofexpertsaroundher andtheorganization,confrontingthesehurdleshead-on.She explains,“Ilearnedhowyoutreatpeoplematters,andyou don'talwayshavetobetheonewiththeanswer,soseek wisdomfromothers.Relationships,knowledge,andtrustare notthevaluesthateveryoneupholds,sowhenyouencounter thosewhodon’t,considerdeeplywhat’satriskbydoing businesswiththem.”Thislessonindiscernment,learned early,shapedherapproachtobuildingenduring partnerships.

ElevatingPathology:Quality,Compassion,Integrity, Innovation

YosemitePathologyoperatesasaphysician-ownedpractice withanadvancedanatomicpathologylaboratory.Itholds CLIAcertificationandfullaccreditationfromtheCollegeof AmericanPathologists(CAP).ItsBoard-Certified pathologistsservehospitalsandoutpatientpractices,offering abroadrangeofspecialtiesinbothanatomicandclinical pathology,supplementedbytargetedsubspecialtytraining.

Thesecomprehensivespecialtiesallowthemtodeliver solutionsthatmeetclientneeds,helpingtheirphysicianand hospitalpartnersadvancepatientcareandhealth managementintheircommunities.Thecompany’score values—Quality,Compassion,Integrity,and Innovation—guideitseverymove.Pinascoemphasizesthat innovationremainscrucialforgrowthandadaptation,but employeesmustfeelconnectedtoitfirst.Byleveraging technology,providingcleardirection,andallowing personnelspaceforindividualgrowth,shebelieves“magic happens,”andtheteambecomesunstoppable.Shehighlights thispointbystating,“Innovationisoneofthecorevalues thatweasanorganizationfocusonnurturingand cultivating.WewereabletobringonCOVIDtestinginjust tendaysduetothespacewegivetoourteamstoinnovate andcreatesolutions.”

Pinascobelievesfocusingonemployeesandclientneedsholdsmore importancethanattentiontocompetitors.Shementions,“Whenour eyesareonourclients,weidentifyareasofopportunitywherewecan providesolutionstohelpthemandaddvaluetotheirpractice, ultimatelyimprovingpatientcare.”YosemitePathologyalsorecently earnedcertificationasaGreatPlaceToWorkfromitsemployees.This, Pinasconotes,servesasatestamenttotheshareholders’and leadership’sfocusoncreatinganopen,inclusive,compassionate, quality-drivenenvironmentwhereemployeescanthrive.

RedefiningAnatomicPathology

Pinascodescribesherorganization’suniqueposition:“Ithinkour organizationisuniqueinthatwehavebeenveryintentionalabout investinginanddevelopinganinfrastructurethatfullysupportsour pathologists’needsandthoseofourclientswhilecreatinganurturing environmentforouremployees.”

YosemitePathologyoffersafullsuiteofconciergeservices,both internalandexternal,toitspathologistsandclients.Theseservices coveranalytics,interfaces,accreditation,logistics,andcompliance. Theyaimtofindqualitysolutionsforoptimalpatientcare.She mentions,“Inthelastdecade,wehavegreatlyexpandedtherangeand depthofourservicesandhavebecomeapremierproviderofanatomic pathologyservicesinNorthernandCentralCalifornia.”Thisexpansion hasnotjustbroadenedtheirreachbutdeepenedtheirimpactonthe communitiestheyserve.

TheCEO’sDailyPractice

AsCEO,Pinascocarriesresponsibilityfor strategicdirection,creatingavisionfor success,anddevelopinganexceptionalteam toachieveit.Sheseesherroleasanopen, genuine,balancedleaderwhostrivesto maintainstabilitywhilepursuingnew ventures.

Whilefuelingthegroup’sgrowth,she understandstheimportanceoftakingbreaksto re-energizeforupcomingchallenges.She engagesinyogaandmeditationtode-stress andunwindfromtheday.Shealsolovesto travel,whichallowshermindtoexpand awarenessandremainfreshandopenfornew ideasforthegroup’sgrowth.Thesepersonal practicesunderscoreherbeliefinholisticwellbeingasacomponentofsustainedleadership.

ChartingtheFuture:Expansionand Education

Pinascooutlinesclearfutureprospectsforthe company.“Ourvisionistocontinueour expansioninterstateandintrastateby acquiringsmallphysiciangrouppracticesthat alsoprovidequalitypathologyservicestotheir communities.”Thisgrowthstrategy,she explains,requiresleaderstobetransparent, agile,andempowering,helpingthenext generationinline.Theyaredevelopinga careerpathprograminpathologyforyoung peopletoexposethemtothisprofessionand thecriticalrolepathologyleadersplayin healthcare.

Sheexpresses,“PathologyLeadership awarenessstartswiththoseofuspracticingit, andweneedtobeginsharingmorewithone another,learningfromeachotherand combiningourstrengthsforbestpractices goingforward.”Hervisionextendsbeyondthe immediatebusiness.Sheaimstosteerthe groupintocontinuingitsM&Abusinessline, expandingitstestmenu,andparticipatingin clinicaltrials.Pinascodoesnotjustleada company;shebuildsasystemdesignedfor resilience,growth,and,ultimately,improved patientcare.

How DIGITAL TWINS

Are Quietly Rewriting the Healthcare Playbook

You’renottheonlyversionofyourselfanymore.

Somewhere—inaserverfarmyou’llnevervisit,running codeyou’llneversee—yourdigitaldoublequietly watchesyou.Itlearnsfromyourbloodwork,your medicalhistory,yourheartbeat.Itdoesn’tsleep.It doesn’tforget.Andit’snotjustrecording.It’sprojecting.

Thisistheworldofmedicaldigitaltwins.Andifyou’re stilltreatingthemlikefuturisticnovelties,you’relate. Thisisn’taboutgadgets.Thisisaboutleverage.Thekind ofleveragethatCEOsuseintheboardroomto outmaneuvertheircompetitors.Thekindofleverage hospitalswillneedtosurviveaworldwherepatients behavelikeconsumersanddatadriveseveryclinical decision.

Let’sbeclear:digitaltwinswon’tjustenhance healthcare.Theywillreplacetheguesswork.

WhatExactlyIsaMedicalDigitalTwin?

Stripawaythetechlingo.Here’sthetruth.

Amedicaldigitaltwinisyourbiologicalreflectionincode.It’s avirtualversionofyou—fedbyyourgeneticprofile, wearables,bloodtests,imagingscans,andmore.Itruns simulations.Itwatchesfordeviations.Itruns“what-if” scenarioslongbeforeyourbodybreaksdown.

It’snothypothetical.It’smathematical.

Builtwithmachinelearningmodelsandreal-timephysiological data,thetwincansimulatehowyourbodymightrespondto differenttreatments,diets,drugs—evenfuturediseases.

Thisisnolongeralabprototype.It’sbeingdeployedrightnow inpilotprogramsfromBostontoBarcelona.Andtheearly signals?They’renotjustpromising—they’redecisive.

Here’s

WhatYou’reMissingIfYou’reNot PayingAttention

Mosthealthcaresystemsstilltreatpeoplelike theyliveinsidespreadsheets.Age,weight, BMI.Baselines.Averages.Thesearen’t insights—they’reshortcuts.

Adigitaltwindoesn’tcareaboutaverages.It models you—downtothecellularlevelif needed.

Andhere’sthestrategicshift:

Withatwin,doctorsstopreacting.Theystart anticipating.

CaseinPoint:TheHeartThatWarnsYou BeforeItFails

AttheBarcelonaSupercomputingCenter, researchersdidn’tbuildatool.Theybuilta revolution:adigitaltwinofthehumanheart calledAlyaRed.

100millionvirtualheartcells.50equations percell.Ittakes10hourstosimulate10 heartbeats.Whydoesthatmatter?

Becausethisheartcanspotfailuresbefore symptomsshowup.Itseeswhatmedication willfixyou before youneedthemedication. That’snottheory.That’strajectory.

Imagineyou’reacardiacpatient.Wouldyou ratherwaitforchestpain—orseeasimulation flagdeterioratingbloodflowinreal-time?

ThisiswhatAlyaReddelivers.Strongflows appearasredandorange.Sickzonesglow blueandgreen.Thecolortellsthestory. Doctorsdon’tguess.Theyact.

Let’sTalkStrategy:WhatDigitalTwins ActuallyChange

1.TheyKilltheStandardProtocol

Yourtreatmentisn’tbasedonpopulationleveltrialsanymore.It’sbasedonyourown future.

CEOstalkabout“precisionstrategy.”Thisis “precisioncare.”It’sthesameprinciple. Understandthelandscape,simulateoutcomes, executetheoptimalplay

2.TheyFliptheHealthSystemIncentives

Today,providersprofitwhenpeoplestaysick longer.Buttwinsenableearlyintervention.That onlyworksinavalue-basedcaremodel.Soif you’renotshiftingyoursystemnow,you’re bettingagainstthetrend.

3.TheyEmpowerthePatient—andForce Transparency

Patientswhoseetheirdigitaltwindon’tstay passive.Theyaskquestions.Theywantreal answers.Andtheycanseewhensomething doesn’taddup.Ifyou’reaprovider,thismeansno morevagueadvice.Yourdatawillbematched againsttheirs.

WhattheSmartSystemsAreDoingRightNow

Let’smakeitreal.

Here’swhatthetop-tierhealthsystemsand tech-forwardclinicsaredoingtodaywithdigital twins:

· RiskMapping:Usingpersonaltwinsto simulatehowlikelyapatientistodevelop diabetes,cancer,orstroke—before any symptomsarise.

· TreatmentSimulation:Tryingoutfive differentchemoregimensonthedigital versionofacancerpatienttoidentifythebest option—before startingasingledose.

· SurgicalPrecision:Pre-testingsurgical proceduresinthevirtualbodytoreducepostopcomplicationsandlowermalpracticerisk.

Thisisstrategydisguisedascare.Anditworks.

ButThere’saCatchNoOneTalksAbout

Digitaltwinsdon’tworkinisolation.Theyneed infrastructure.Cleandata.Securesystems.A clinicalteamthatknowshowtouseinsights—not justcollectthem.

Mostprovidersaren’tready.Andtheoneswhoare? They’renottalking.Becausewhenyougetthisedge, youdon’tbroadcastit.Youscaleit.

Andthatbringsustotheuncomfortabletruth:

Digitaltwinswon’tdemocratizehealthcare.They’ll weaponizeit—forthosewhoprepare.

TheHardQuestionsYouNeedtoAsk

Ifyou’readecision-makerinhealthcare—clinical, operational,orstrategic—askyourself:

· Isoursystemstructuredtotreatpatternsorpeople?

· Doourcliniciansknowhowtointerpretsimulation data?

· HaveweinvestedintheITbackbonethatsupports twin-basedcare?

· Arewestillreactingtodisease…oranticipating it?

Thewinnersinthenextphaseofhealthcarewon’tbetheones withthebestslogans.They’llbetheoneswhoknowwhat’s coming—becausethey’vealreadyseenit.

FinalWord:ThisIsn’ttheFuture.It’sAlreadyHere.

Thephrase“personalizedmedicine”hasbeenaroundfortwo decades.Butnow,itmeanssomethingveryreal.Itmeansyour body,renderedindata.Simulated.Projected.Protected.

InthewordsofoneCTOataleadingbiotechfirm:

“Westoppeddesigningtreatments.Westarteddesigningfutures.”

That’sthedifferencedigitaltwinsmake.

Andifyou’restillthinkingofthisasatechnologystory,you’re missingthebiggerplay.

Thisisastrategystory.Acontrolstory.Asystems dominancestory

Kevin Goodwin

(CEO

-ECHONOUS)

Redefining Healthcare Industry with AI’s Excellence

Thecontinuouslychanginghealthcareandscape requiresleaderstobedynamicaswellas proactive.Tooutsmartthecompetition,Leaders mustbeabletohandlethepresentwhilealso calculating thefuture,comprehendingthepossibilities,anddealing withlegislation.Asthe healthcaresectorisheavily regulated,ahealthcareleaderfacesintensescrutinytoday.

Risingabovetheodds,KevinGoodwin,theCEOof EchoNoushasinculcatedthequalities requiredtobean excellentleaderinthehealthcareindustry.Kevinhas beenintheglobalultrasoundbusinessfor34yearsand hasworkedincommercialhealthcarefor41years.He hasbeenaleader,innovator,andstudentof“pointofcare ultrasound”(POCUS)for morethan20years.

SteppingStones

Kevindecidedtopursueacareerinhealthcareinhigh schoolafterhismentortoldhim:“You’ll always have a job because healthcare is a booming business, it’s always going to be needed.” Heenteredcollegeintendingto majorinHospitalManagement,butaftercompletinga year-longinternshipatanearbyhospital,hechangedhis mindandchosetoworkintheprivatesector.Kevin beganworkingforAmericanHospitalSupplyrightoutof college,enteringtheworldofcommercialhealthcare, privatesitehealthcare,andcorporatedeliveryofgoods andservices.Fouryearslater,hequitthatorganization andjoinedPictureInternational.

Atthattime,importanttoolswereaccessible,nuclear scanningwasexpanding,andMRI,CTscanning,and ultrasoundwereallexperiencingrenaissance.Kevingot intotheultrasound businessin1987andworkedfora companynamedATL.HeeventuallyrelocatedtoSeattle totakethepositionofDirectorofTraining,andafter workingcloselywiththeCEO,hewasnamedtheheadof ultrasound.Thefirsttoofferpoint-of-careultrasoundwas formed.POCUSiswhatSonositecreatedandled.

InaugurationofEchoNous

AftersellingSonositein2012,KevinfoundedEchoNous afewyearslater.EchoNoushasprovedovertimeto becomethemarketleaderintheminiaturizationofhighqualityultrasound.ThepurposeofEchoNousistouse computervision,machinelearning,anddeeplearningto improvetheuseofultrasoundtechnologyinhealthcare. Thecompanystrivestouseahighlyinnovativehardware platformthatcanbecarriedbyhandandhasthe performanceandfunctionalityofamuchbigger,more expensivedevice.

EchoNoushastakentheleadershippositionofapplying deeplearning,machinelearning,and computervisionto howallultrasounddevicesareusedfromfronttoback. Forteacherstudentcommunication,thecompanyhas softwarethatautomatesqualityassuranceandcoaching. Theparadigmofwhatcanbedonewithhand-carried ultrasoundequipmenthasbeencompletelydismantledby

EchoNous’Kosmoshardware.Itimagesincrediblywell, andmoredoctorsarelearningthiseachpassingday With itsmanylayersofAI,EchoNous focusesonimage acquisition,whichisthemostdifficultaspectof ultrasoundduetouser dependence,imageinterpretation, logicalcalculations,anddecision-makingattheend.

ImpactfulandReliableServices

WiththehelpofEchoNous,healthcareorganizationsand othercompaniesthatmakevalves cannowuncover peoplewhoareasymptomaticbutneverthelessillwith conditionslikeheart failureandvalvediseaseand identifytheirsymptomsbeforetheybecomevisible.One of EchoNous’mostnotableservicesandsolutionsisa mixofhigh-qualitytechnologythat enablescliniciansto strolltothepatient'sside,bedside,orwhereverthepatient maybeand receiveaqualityimagemorequicklywithAI assistance.

Thisisthefirsttimeinthemedicalhistoryofultrasound thatadiseasecanbefoundbefore symptomsappear.The equipmentusedbyEchoNousissufficientlyreliableto completethe task,butitisalsoaffordable,simpleto operate,highlyautomated,andAI-affected.This device

hasopenedupanewwindowofopportunityforreal, authenticpublichealthandearly diseasediagnosis, amongotherthings,forheartfailurewithintactejection fractionandother valveconditions.

ResponsibilitiesandCopingMechanism

AsCEO,Kevin’sprimaryroleistogeneratecapital, guidethefirmtowarditsstrategic objectives,andhelpit becomethebestitcanbewhilecreatingabusiness model.ItisKevin whokeepsanideaofwhatthatmodel willentailandcertainguidingprinciplesinmind.This includesincreasinggrossmargins,revenuegrowth,and ultimatelyprofitmargins.Thetwo maingoalsofthis initiativearetoraisemoneyandhirehighlyqualified personnelatalllevels oftheorganization.

Kevinbelievesthatleadersinallfieldsneedtolookafter theirphysical,mental,emotional, andspiritualwellbeing.Leadersoughttobecapableoflookingafter themselves.Hebelievesthattosustaininthelongrun, live,andprosper,isthechallengeyoumustconcentrate on everyday.Heworksoutalotanddoesyogatwicea weektostayproactiveandmaintainahealthywork-life balance.Everyevening,heallowshimselfsome

downtimeandsteersclear of80-hour workweeks.Hearguesthatinvestingin restandrecuperationatnight,for instanceonweekends,isjustascrucialas engagingineffortandhardlabor

BrightFuturewithAI

AccordingtoKevin,abusinesslike EchoNouswouldupendthemiddle marketforultrasound equipment,which consistsoflargerdevices,withitslowcost,high-performanceproduct. EchoNous’sequipmentperforms similarlytothosemiddle-market machinesintermsofsize.

Themachine’smeasures,includingthose forimaging,Doppler,bloodflow velocity,and otherAIparameters,areall onparwiththoseoflargemachines.

KevinbelievesdeeplearningandAIhave agreatchancetoautomatethelabordone by caregiversandmakelearningquicker andsimpler.AIwillreducetime,enhance accuracy, andincreasetheamountof physicianandcareprovidertime availableforpatients,whilethe company’shardwarewillsavebothtime andmoney AccordingtoKevin, “EchoNous is not just planning for the future but also fostering the future that healthcare requires.”

“TO SUSTAIN IN THE LONG RUN, LIVE, AND PROSPER, IS THE CHALLENGE YOU MUST CONCENTRATE ON EVERY DAY.”

Let’stalkabouttherecentpast.

Afewyearsago,aglobalcrisis triggeredafrantic, disorganizedgoldrush.Thegoldwas “telehealth.”Everyhealthsystem,clinic, andentrepreneurscrambledtostakea claim,launchingsimple,standalone applicationsthatdidlittlemorethanbolt avideocameraontoaschedulingtool. Theywerecelebratedasinnovators.

Thatgoldrushisover.Thebattlefieldis nowlitteredwiththecasualties.

Manyofthoseearly,flimsyplatformsare failing.Patientadoptionhasplateaued, clinicianburnouthasworsened,andthe promisedcostsavingshavefailedto materialize.Why?Becausethesewere notstrategicplatforms.Theyweredigital waitingrooms—commoditieswithno defensibility,noloyalty,andnoreal integrationintothecomplexmachinery ofhealthcaredelivery Theywerea panic-drivenreaction,nota forward-thinkingstrategy

Ifyouarealeaderinthisspace,youmust understandthis:continuingtoinvestina simple“telehealthapp”islikearrivingat adepletedgoldminewithashovel.The easygoldisgone.

Theopportunitynowisinfinitelylarger andrequiresmorestrategicdiscipline. Thenextgenerationofwinnerswillnot bebuildingapps.Theywillbebuilding integrated,defensibleVirtualCare DeliveryPlatforms.Thedifference betweenthesetwoisnotsemantic.Itis thedifferencebetweenfleetingsurvival andmarketdominance.

TheAutopsyofaFailedGoldRush: WhyFirst-GenerationTelehealthIs Dying

Towinthefuture,youmustfirstdissect thefailuresofthepast.Thefirstwaveof telehealthappsmadethreefatalerrors.

1.TheyFellintotheCommodityTrap: Astandalonevideoconsultationapphas zerostrategicmoat.Itisacommodity,no differentfromadozenothers.Ifyour onlyvaluepropositionisavirtualvisit, youarecompetingwitheveryother provider,includingretailgiantsand venture-backedstartupswhocan outspendyouandundercutyouonprice. Patientloyaltytoacommodityiszero. Theywillusewhateverischeapestor mostconvenientinthemoment.You havebuiltadigitalturnstile,notalasting relationship.

2.TheyCreatedaDisconnectedExperience: Mostoftheseappsexistonanisland,completely detachedfromthecoresystemsofcare.The clinicianhastoexittheirEHR,logintoaseparate system,conductthecall,thenreturntotheEHRto documentit.Thepatienthasaseparatelogin,a separateinbox,andaseparateexperiencethatfeels divorcedfromtheiroverallcarejourney.This fragmentationcreatesmoreworkforyourstaffand adisjointed,frustratingexperienceforyour patients.Itsolvesoneproblem(thevisit)by creatingthreemore(documentation,navigation, andfollow-up).

3.TheyWereEmptyWaitingRooms:Themantra was“ifyoubuildit,theywillcome.”Itwasalie. Buildingthetechnologydidnotmagicallyrewire decadesofpatientbehaviororcomplexclinical workflows.Theseappsweresolutionsinsearchofa definedproblem.Theylackedaclearstrategyfor clinicianadoptionbeyondatop-downmandate,and theyhadnoplanforpatientengagementbeyondthe initialnovelty Theywereemptydigitalrooms waitingforpeoplewhonevershowedupin sustainablenumbers.

TheStrategicPivot:From“App”to“Platform”

Thesmartmoneyisnolongerfunding“telehealth apps.”ItisfundingthecreationoftrueVirtualCare DeliveryPlatforms.Aplatformisnotatool;itisa fundamentalre-architectureofhowyoudeliver care.Itisbuiltonthreestrategicpillarsthatcreatea defensible,high-valuesystem.

Pillar1:DeepClinicalWorkflowIntegration (TheEngine)Atrueplatformdoesnotsitontopof theworkflow;itiswovenintoitsveryfabric.Itis theengine,notasidecar.

· YourMandate:Theplatformmusthavedeep, bidirectionalintegrationwithyourEHR(Epic, Cerner,etc.).Itmustpullpatientdatatogivethe cliniciancontext before thevisitandpushvisit data,notes,andordersbackintotheEHR automatically.Itautomatesscheduling,coding, andbilling.Thegoalissimplebutpowerful:the platformmustreducetheclinician’stotal workload,notaddtoit.Thisistheonlywayto achievetrue,enthusiasticadoptionfromyour mostvaluableasset:yourproviders.

Pillar2:ContinuousPatientEngagement(TheMoat) Acommodityappistransactional.Aplatformis relational.Itsjobisnotfinishedwhenthevideocall ends.Itisdesignedtomanagethepatient’sjourney between visits.

· YourMandate:Youmustbuildamoataroundyour patientrelationship.Thismeansintegratingtoolsthat createcontinuousvalue.RemotePatientMonitoring (RPM)forchronicdiseasemanagement,wheredaily vitalsaretrackedautomatically.Secureasynchronous messagingfornon-urgentfollow-upquestions. Personalizededucationalcontentpushedtothepatient basedontheircondition.Integratedprescription managementandadherencetracking.Thisecosystem ofcontinuouscarecreatesimmense“stickiness.”It makesswitchingtoacompetitor’scommodityapp unthinkableforthepatient.

Pillar3:DataasaStrategicAsset(TheFuel)Asimple appgeneratesarecordofatransaction.Aplatform generatesalongitudinaldatastream.Thisisitsfuel.

· YourMandate:Youmusttreatthedatafromyour platformasacorestrategicasset.Byanalyzingpatient engagement,RPMdata,andclinicaloutcomesover time,youcanmovefromreactivesick-careto proactive,predictivehealth.Youcanidentifyat-risk patientsbeforetheydecompensate.Youcanprove yourplatformimprovesoutcomesandlowersthetotal costofcare.Thisdataiswhatyouwilluseto negotiatefavorabletermswithpayersandto demonstrateyourclinicalsuperiorityinthemarket.

TheExecutionMandate:ForgingYourVirtualCare Platform

Buildingatrueplatformrequiresalevelofstrategicrigor absentfromthegoldrush.

1.DefineYourBeachhead,ThenDominate:Donottry tobeeverythingtoeverypatient.Thatisarecipefor failure.Instead,identifyaspecificclinicaloroperational beachheadwhereyoucanestablishdominance.IsIt post-operativeorthopediccare,whereRPMcanreduce readmissions?Isitchronicdiabetesmanagement,where continuousengagementiskey?Isitdermatology,where asynchronouscaremodelscanbehighlyefficient?Pick oneniche.Perfectyourplatform,proveitsclinicaland financialvalue,andthenexpandfromthatpositionof strength.

2.PartnerwithanArchitect,NotaBuilder:Stoplooking fora“telemedicineappdeveloper.”Youarenotbuilding fromagenericfeaturelist.Youneedtopartnerwitha virtualcarearchitect.Thisisateamwhosefirstquestions areaboutyourclinicalworkflows,yourEHRintegration points,andyourbusinessgoals—notyourcolorpalette. Theirdeepexperiencewithhealthcareinteroperability standards(HL7,FHIR)andEHRsystemsisinfinitelymore valuablethantheirabilitytocodeaslickfront-end.Vet themontheirstrategicunderstandingofhealthcaredelivery, notjusttheirtechnicalskill.

3.TheFutureisAsynchronous:Themostsignificant, immediateopportunityforefficiencyandscaleisnotAIor blockchain.Itisasynchronouscare.

Thismeans“store-and-forward”interactionswherepatients andclinicianscommunicateontheirowntime.Apatient sendsasecuremessagewithaphotoofaskincondition. Adermatologistreviewsitbetweenscheduled appointmentsandsendsbackadiagnosisandprescription. Adiabeticpatientuploadstheirglucosereadings,anda nursereviewsthedataandadjuststheircareplanlaterthat day.

Thismodelbreaksthetyrannyoftheone-to-one,real-time appointment.Itallowsonecliniciantomanageamuch largerpanelofpatientswithincredibleefficiency

Yourplatformmustbebuiltfromthegrounduptosupport bothsynchronous(livevideo)andasynchronous workflows.Thisdualcapabilityisamassivecompetitive advantage.

TheChoice:DigitalWaitingRoomorVirtualCare System?

Thefirst,chaoticchapterofremotecareisclosed.The marketismaturing,andthestandardsforsuccessare risingdramatically.Continuingtooperateastandalone, commoditytelehealthappisnolongeraviablestrategy.It isaslow-motionsurrender

Theopportunitybeforeyounowistobuildadurable, strategicasset.Tomovebeyondthedigitalwaitingroom andconstructatruesystemofvirtualcaredelivery—one thatisdeeplyintegrated,continuouslyengaging,and fueledbydata.

Thisistheworkofseriousleaders.Itrequiresinvestment, discipline,andaclear-eyedviewofthecompetitive landscape.

So,thechoiceisyours.Willyoukeeppatchingtheroofof asimpledigitalwaitingroom?Orwillyouarchitectthe integratedvirtualcaresystemthatwilldefinethefutureof yourorganizationandbecometheengineofitsgrowth?

The Strategic Alchemist MENZO HAVENGA

on Building a Different Kind of Biopharma Partner

Thejourneyfromapromising biopharmaceuticalconceptinaresearchlab toalife-changingmedicinereachingpatients isfraughtwithchallenges.It’sapathdefinedby scientifichurdles,immensecapitalrequirements, complexregulatorylandscapes,andthedelicate processofscalingbiologicalmanufacturing.Formany biotechstart-upsandevenlargerpharmacompanies, navigatingthispipelineefficientlyisamake-or-break proposition.TheyoftenturntoContractDevelopment andManufacturingOrganizations(CDMOs),butthe relationshipcanbetransactional,lackingthedeep scientificandstrategicpartnershipneededtotruly accelerateinnovation.

ThisisthegapMenzoHavenga,PresidentandCEO ofBataviaBiosciences,setouttofill.Amolecular virologistbytrainingwithnearlythreedecadesof experienceinbiopharmaceuticalR&Dand management,Havengarecognizedtheneedfora differentkindofpartner–onethatactsnotjustasa serviceprovider,butasastrategicguideand technologicalinnovatorembeddedwithintheclient’s journey.Hispersonalmantra,“Betterownhalfof somethingthanallofnothing,”hintsatthe collaborative,value-sharingphilosophythatunderpins Batavia’smodel.

FromResearchScientisttoEntrepreneurialLeader

Havenga’strajectoryprovidesacompellingcasestudy inleveragingdeeptechnicalexpertiseintostrategic businessleadership.AfterearninghisPhD,hecuthis teethasaseniorscientistatIntroGene(laterCrucell), contributingsignificantlytofoundationaltechnologies likeadenoviralvectors–aplatformfamouslyused yearslaterbyJohnson&JohnsonfortheirCOVID-19 vaccine,withHavengacreditedasaco-inventor.Rising throughR&DleadershiprolesatCrucell,hegained

crucialexperiencemanaginglargescientific organizationsandnavigatingthecomplexitiesof corporateacquisitionsinthebiopharmaspace.

Hisentrepreneurialpivotcamein2010.Recognizingan opportunitytoofferspecializedbioprocessdevelopment expertiseoutsidetheconfinesofalargepharma company,hepartneredwithChrisYalloptospinBatavia BiosciencesoutoftheTNOorganization,aDutch appliedresearchinstitute.Thisspin-outitselfembodied the“ownhalf”philosophy,leveragingTNO's infrastructureandinitialsupportwhilegainingtheagility ofanindependententity.

BuildingaDifferentiatedValueProposition

BataviaBioscienceswasconceivednotasahigh-volume, low-costCDMO,butasacenterofexcellenceoffering high-qualityservicesforearly-stagebiopharmaceutical development.Theirinitialfocusspannedeverythingfrom DNAcloningandcelllinedevelopmenttoprocessscaleupandproductcharacterization.However,thestrategic visionquicklyexpandedbasedondirectclientfeedback.

ListeningintentlytotheneedsoffoundersandCEOs navigatingtheperilous“benchtoclinictomarket” pathway,Bataviarealizedclientsrequiredmorethanjust isolatedservices.Theyneededapartnerwhounderstood theentireproductdevelopmentlifecycle,includingthe inherentrisksandstrategicdecisionsateachstage.This ledtothedevelopmentoftheir‘ProductDevelopment Plan’(PDP)servicespackage–essentiallya comprehensivebusinessplantailoredtotheclient’s specificproduct,coveringmanufacturing,clinical, regulatory,IP,andcommunicationstrategies.Thismove transformedBataviafromaserviceproviderintoa strategicthoughtpartner,offeringalevelofguidance typicallyreservedforin-houseexpertiseorhigh-level consultants.

CentraltoBatavia’sdifferentiationisits investmentinproprietarytechnology platformsdesignedtotacklespecific,highimpactchallengesinbiopharmaceutical ® manufacturing.TechnologieslikeSTEP ® (improvingproductyield),SCOUT ® (enhancingscale-up),andHIP-Vax offer clientstangibletechnicaladvantages, savingtimeandreducingcostsin developmentandmanufacturing. Combinedwithaccesstoadiversearrayof viralvectorsystemsandcelllines,Batavia providesalevelofintegratedexpertiseand technologicalcapabilitythatdistinguishes itfrommanycompetitorswhooffermore commoditizedservices.

NavigatingtheGrowthCurve:Strategic PivotsandScaling

Batavia’sjourneyfromasmallspin-outto asignificantplayerisatestamentto strategicadaptabilityandbolddecisionmakingdrivenbymarketdemand.Starting withjust7employeesand300square metersoflabspace,thecompanyrapidly attractedclientsbasedonthedeep experienceofitsstaffandthequalityofits initialservices.

Respondingtothisdemandrequiredrapid scaling.TNO’sinitialflexibilityin accommodatingmultiplelabexpansions wascrucial.Apivotalstrategicmovecame in2011,justayearafterlaunch,withthe acquisitionofXendoPharmaServices. Thisbroughtin117highlytrained professionals,providinganimmediate, significantinjectionofhumancapitaland expertise,acceleratingthecompany’s growthfarbeyondwhatorganichiring alonecouldachieve.

Anothercriticaljuncturearrivedin2012 when,againdrivenbyclientneeds, Bataviaundertooktwomajorexpansions simultaneously:establishingasubsidiary inBostontoaccessthevitalUSbiotech ecosystemandaddingGood ManufacturingPractice(GMP) manufacturingservicesintheNetherlands.

Batavia Biosciences

ThedecisiontomoveintoGMPwas particularlysignificant,requiringsubstantial investmentinqualitysystems,expertstaff (QC,QA,QP),andfacilities.Havengaand histeaminitiallyaddressedthefacilityneed throughacleverstrategyofleasingGMP spaceonaproject-by-projectbasis,enabling themtobegindeliveringclinicalproductsand validatethemarketdemandbefore committingtobuildingtheirownlarge-scale facility(acapabilitytheyareaddingbylate 2025withanewcommercialproduction facility).Thisiterativeapproachtocapitalintensiveexpansionmitigatedriskwhile allowinggrowth.

Thefinancialresultsunderscorethesuccess ofthesestrategicmaneuvers.Bataviahas demonstratedstrongyear-on-yearrevenue growth(approx.33%CAGR),scalingfrom €1Matlaunchtosubstantiallyhigherfigures, attractingadiverseclientbaseincludinga significantportionofnon-profitandglobal healthorganizations–areflectionofthe company’sunderlyingmissiontocontribute totheaffordabilityandaccessibilityof medicines.Their97%successrateinGMP projectsisakeymetrichighlighting operationalexcellenceandthequality outcomesderivedfromtheirintegrated model.

TheLeadershipEquation:Plan,Dive,and Partner

Beyondstrategyandtechnology,Menzo Havengaemphasizesthatpeoplearethecore ofBatavia’ssuccess.Heattributesthe company’shighpercentageofreturning clientstothehardwork,dedication,and experienceofthestaff,enablingthe “customerintimacy”model.Attractingand retainingtoptalentinthecompetitive biopharmaspaceisachievednotjustthrough competitivecompensation,butbyoffering compelling,purpose-drivenwork–projects contributingtoglobalhealth,vaccine affordability,orimprovingliveswithgenetic conditions.Flexibility,careerplanning,and continuoustrainingareviewedascritical investmentsinhumancapital.

Havenga’sleadershipphilosophyisdistilled intopowerful,actionabletenets.“Planyour diveanddiveyourplan”underscoresthe importanceoffocusedexecutiononcea strategicdirectionisset–acruciallessonfor entrepreneursnavigatingcountless distractions.Finding“therightpeopleto followthedream”highlightstheabsolute necessityoftalentacquisitionandteam building.Being“honestabouttherisksand rewards”andbuilding“win-winsituations” speakstothetransparentandcollaborative approachneededtoattractsupporters, partners,andinvestorsthroughoutthe challengingscale-upphase.Hisinitial“Better ownhalfofsomethingthanallofnothing” philosophyisevidentinthesuccessfulspinoutstructure,thecollaborativeclient relationships,andthestrategicdecisionpoints alongBatavia’sgrowthpath,culminatingin thecompany’ssaletoCJCheilJedang corporationin2021–amovethatlikely providedresourcesforfurtherexpansionand marketreach.

Inanindustrygrapplingwithacceleratingthe paceofinnovationwhileensuringqualityand accessibility,companieslikeBatavia Biosciences,ledbystrategicthinkerslike MenzoHavenga,offeravaluablemodel.By combiningdeepscientificexpertisewitha strategic“thoughtpartner”approach,investing indifferentiatingtechnologies,andprioritizing humancapitalandcollaborativerelationships, theyarenotjustparticipatinginthebiopharma ecosystem;theyareactivelyhelpingtoshapea moreefficient,effective,andultimatelymore patient-centricfuture.Batavia’sjourney providesapotentcasestudyinhow specializedexpertise,strategicallyapplied,can createsignificantvalueandimpactonaglobal scale.

Why most

HEALTHCARE CONTACT CENTERS FAIL

And What StrategistsAre Doing Differently

Let’snotsugarcoatit.

Mosthealthcarecontactcentersarebuiltonbroken assumptions.Theystilltreatpatientcommunicationlikeahelp deskinsteadofagrowthengine.Leadersinstallnewtechand thinkthey’ve“innovated.”Theyhaven’t.Patientsstillsuffer throughlongwaits,repeatedtransfers,androboticscripts. Behindthescenes,calldatadiesinsilos,AIbuzzwordsfly aroundlikeconfetti,andnobodytrackstheonemetricthat actuallymatters:trustbuiltperinteraction.

Here’sthetruthnovendorwilltellyou:

Ifyourcontactcenterisn’tdirectlymakingpatients’lives easierwithin30secondsorless,it’salreadycostingyou—in no-shows,badreviews,andlifetimevalueerosion.

Thegoodnews?Asmallbutgrowinggroupofhealthsystems areflippingthescript.They’retreatingthecontactcenternot asasupportfunction,butasthefrontlineofexperience, loyalty,andrevenue.Thisishowthey’redoingit.

ActI:HowthePatientJourneyBreaksat“Hello”

Let’sstartwheretheproblembegins:thefirstcall.

Amotherphonesintorescheduleherchild’sappointment. She’sdirectedto“Press1forbilling,2forappointments,3for testresults…”Youknowthedrill.Sevenminuteslater,she finallyreachessomeone—onlytobetoldshe’scalledthe wrongdepartment.“Letmetransferyou.”Shewaitsagain.

Atthispoint,she’snotthinkingaboutyourcarequalityor physiciancredentials.She’sthinking: “If it’s this hard to talk to someone, how hard will it be to get treatment when it matters?”

Thatmomentrightthere?That’swheretrustdies.

Thisisn’tabouttech.It’saboutexpectations.Yourpatientsuse appstopayforgroceries,bookflights,andtransfermoney— allinseconds.Whenyourcontactcenterexperiencelags behindtheirdailynorm,youlookarchaic.Andtheygo elsewhere.

ActII:Why“DigitalTransformation”OftenJustMeans MoreConfusion

In2024,57%ofhealthcareexecutivessaid“improving consumerexperience”isatoppriorityfordigitalinvestment. It'sanicesentiment.Buthere’swhatreallyhappens:

· TheydeployAIforcallroutingbutdon’tredesign thejourney

· Theyaddachatbotthatsimplyredirectsusersto thesamephoneline.

· Theymigratetocloud-basedsystemsbutforget integration.

Sonowtheyhavemoredashboards,morevendors,and morenoise—butthepatientstillhitsthesamewall.

Realtransformationdoesn’tbeginwithtools.Itbegins withpurpose What,exactly,doyouwantthepatientto feelanddoaftereveryinteraction?Ifyourteamcan’t answerthatinonesentence,allthecloudmigrationsin theworldwon’thelp.

ActIII:WhattheWinnersDoDifferently(The TampaPlaybook)

Nowlet’stalkaboutthefewwhogetitright.

TakeTampaGeneralHospital.TheirExperienceCenter didn’tjustconsolidatecalls—itconsolidated intent. Everyinteractionhadonemission:resolvefrictionfast.

Theydidn’tstopatcalls.Theystudiedevery touchpoint:appointmentscheduling,follow-ups, cancellations,reminders.Thentheybuiltprocesses aroundthosekeymoments.Result?

· 47%jumpinonlineappointments.

· 75%increaseinappointmentslotsmadeavailable.

· 20%dropinno-shows.

That’snot“digitization.”That’soperationsintelligence executedlikewarstrategy.

AnothersysteminWisconsinwentfurther.They tackledlongholdtimes,highcallabandonment,and poorself-service.InsteadoftinkeringwiththeIVR, they:

· Deployedanintelligentvoiceassistanttrainedon real patientqueries.

· IntegratedEHRssothebotcouldpullappointment andbillingdatainreal-time.

· Shifted20%oftotalinteractionstoself-service.

· Gotcallabandonmentsunder5%.

Now80%ofcallsgetansweredinunder30seconds. Patientsstay.Revenueflows.Thecontactcenter becomesaconversionengine,notacostcenter.

ActIV:TheRealLeversBehindThisShift(NotWhat YouThink)

Sowhat’sreallydrivingthistransformation?

It’snotAI.Notcloud.Notevenomnichannel.

Theleaderswinningthisgamehaveruthlesslyfocusedon fivekeylevers:

1. TimetoResolution:Everyextrasecondcostsyou goodwill.Best-in-classcentersresolve85%ofpatient queriesinundertwominutes.That’syourbenchmark.

2. IntelligentEscalation:Mostsystemspushproblems downtoTier1agents.Winnersescalatestrategically— lettingautomationhandleroutinetasksand empoweringtrainedagentstostepinwhereitmatters most.

3. ProactiveOutreach:Don’twaitforpatientstocall. Sendreminders.Pushfollow-ups.Offercheck-ins. Patientsfeelcaredfor before theythinktoask.

4. UnifiedDataAccess:Ifyouragentcan’tseethe patient’sbillinghistory,appointmentschedule,and communicationtrailinonescreen,you’refighting blind.

5. RealFeedbackLoops:UseAInotjustforroutingbut toextractsentimentfromcalls.Knowwhatfrustrates patients before itbecomesapattern.

Andyes,compliancematters.HIPAA.Datasecurity.But that’sthefloor,nottheceiling.Securitywithoutempathy stilldrivespeopleaway.

ActV:TheDeathofthe“CallCenter”—AndtheRise ofPatientOps

Thisisn’taboutfixingadepartment.It’saboutreinventing thewayyourorganizationcommunicates.

Theterm“contactcenter”willdie.Whatwe’rebuilding nowisPatientOps—thefull-stackoperatingsystemfor personalized,real-time,lifetimepatientsupport.

Thatmeans:

· Movingfromreactiveservicetoproactiveexperience design.

· Treatingeverytouchpointasabrandingmoment.

· Trainingagentsnotasscript-readersbutasexperience architects.

· Usingtechtocreatehumanbandwidth—notreplaceit.

Thecontactcenterisyournewfrontdoor. Ifit’scluttered,slow,andoutdated,your patientwillneverstepinside.

ActVI:IfYou’reSerious,Bringin Killers—NotConsultants

Thistransformationisn’taDIYproject. Justaspatientsseekspecialistsfor complexneeds,healthcaresystems shouldstoprelyingongeneralisttech teams.

Youwantpartnerswho:

· Buildblueprintsforjourneyredesign —notjustfeaturechecklists.

· Offermanagedservicesthatactually delivermeasurableoutcomes.

· Runtrainingworkshopsthatelevate everyagentintoaretentionasset.

· Aligntheirperformanceincentives withyourpatientsatisfaction metrics.

FirmslikeCDWdon’tjustsellsoftware. Theyorchestratestrategy Theyco-own results.That’sthekindofpartnershipyou needifyou’redoneplayingcatch-up.

FinalWords:TheRealStakesof Inaction

Stillthinkingof“upgrading”yourcontact centernextyear?Letmepaintthereal risk.

Everytimeapatienthearsabusytone,or getstransferredtothewrongdesk,or doesn’tgetafollow-up—they’re formingaquietopinion:

“This place doesn’t care about me.”

Thatthoughtdoesn’tgetloggedina CRM.Butitdrivestheirnextdecision. Andyournextrevenuereport.

Yourcontactcenterisnotasideproject. It’syourbrand’sheartbeat.Fixit—or flatline.

There’saquietrevolutionbrewinginthe pharmaceuticalworld.Itdoesn’tinvolveablockbuster newdrugoragleaming,billion-dollarresearchlab. Instead,ithingesonsomethingfarmorefundamental,yet deceptivelycomplex:truth.Or,asMortenOlesen,the thoughtfulfoundingpartnerofCIMS,wouldputit,“data integrity.”It’saphrasethatmightsounddry,perhapsevena littleanodyne.Butinthehigh-stakesgameofdeveloping medicinesthatwilltouchmillionsoflives,theunassailabletruth ofdataisn’tjustimportant;it’sthebedrockuponwhich everythingelse–safety,efficacy,trust–isbuilt.

OlesenhasaKierkegaardianphilosophythatunderpinshis company’smission,adecidedlyDanishapproachtoaglobal challenge:“Ifoneistrulytosucceedinleadingapersontoa specificplace,onemustfirstandforemosttakecaretofindhim whereheisandbeginthere.”Forpharmaceuticalcompanies navigatingthelabyrinthinepathofclinicaldrugdevelopment, “wheretheyare”isoftenaplaceofoverwhelmingdata,a cacophonyofinformationwherethesignalofgenuineinsight canbeeasilylostinthenoiseofmismanagement.“Decisions basedonlow-qualitydata,”Olesenstateswiththecalm assuranceofamanwhohaswitnessedthealternative,“canlead tomismanagement.”It’sapoliteunderstatementforpotentially catastrophicoutcomes.

Imagine,foramoment,thejourneyofanewdrug.It’snota linearsprintbutagruelingmarathon,involvingcountless researchers,clinicians,andpatients,generatingmountainsof dataateverystep.Everybloodtest,everypatient-reported outcome,everymanufacturingvariable–itallbecomespartof anenormous,sprawlingpuzzle.Inthislandscape,CIMS emergesnotjustasaserviceprovider,butasakindofdata

cartographer,chartingacoursefromchaostoclarity. Theyspecializeinclinicaldataintegration,afieldthat soundstechnicalbecauseitis,butatitsheart,it’s aboutmakingsenseofthedeluge.

Thinkofitlikethis:intheoldworld,information trickled.Today,itfloods.Andwhilemoredata should meanbetterdecisions,itoftenjustmeansmore opportunitiestogetthingswrong.Asingleflaweddata pointinavastdatasetcanbethebutterflywingthat triggersahurricaneofwastedresources,delayed therapies,anderodedtrustwithregulatorybodieslike theFDAorEMA.ThisiswhereCIMS’sdedicationto dataintegrity,inspiredbyISO9001:2015risk-based thinkingandwhattheycallthe“3*Tframework” (Truth-Trust-Traceability),becomesparamount.They don’tjustmanagedata;theycurateit,ensuringit’s accurate,validated,and,crucially,verifiable.It’sabout buildingasupplychain,notforphysicalgoods,butfor informationitself–anInformationSupplyChain Management(ISCM)systemwhereeverylinkis fortifiedagainsterrorandambiguity

Thisisn’tjustabouttickingregulatoryboxes,though that’sasignificantpartofit.Robustdataintegrity, Olesenrightlypointsout,can“reducethefrequencyof audits,”savingcompaniesinvaluabletimeandmoney Butthebiggerwinistheconfidenceitinstills–confidencethatthelife-alteringdecisionsbeingmade arebasedonafoundationofunshakeablefact.CIMS achievesthisthroughasuiteoffivestandardizedtools, meticulouslydesignedforkeyregulatoryoperations fromvendormanagementtoaudits.Theresult? Streamlinedprocessesand,often,significantcutsin trialexecutiontime.It’stheKaizenprincipleof continuousimprovement,appliedtotheveryDNAof drugdevelopment.

TheSweetSpot:AGlimpseintotheFuturewith GLUCARE

Theabstractchallengeofdataintegrityfindsa tangible,andprofoundlyhuman,expressionin projectslikeGLUCARE.Here,thestakesare intenselypersonal:managingdiabetes,acondition affectingastaggering463millionpeopleworldwide. Currentcontinuousglucosemonitors(CGMs)area marvel,buttheyhaveashelflife,typicallyupto180 days,necessitatingrepeatedsurgicalreplacements. Thisisn’tjustinconvenient;it'scostly(around€3000 perpatientannually)andcarriesinherentrisks.

TheGLUCAREconsortium–apowerhousecollaboration includingZimmer&PeacockfromNorway,SafeImplant TechnologyApS(SIT)fromDenmark,andAalborg University–isaimingforaparadigmshift.Theiraudacious goal,backedbya€1.3millionEurostarsgrant,istodevelop thefirstlong-term(over two years)implantablebiosensor forCGM.Thisisn’tjustanincrementalimprovement;it’sa leap.Centraltothisambitionisanovelsurfacecoating, GP5,patentedbySIT,designedtodramaticallyreducethe body’snaturaltendencytorejectforeignobjectsand improvesubcutaneousresidencytime.

Butbuildingsuchadeviceisanorchestraofexpertise. Microsensorengineersmustdesignsensorsofexquisite precision.Circuitdesignerscrafttheelectronics.Software programmersdevelopalgorithmstointerpretthedata. Medicalchemistsensurebioactivecompoundsremain stable.Immunologistsstudythebody’sresponse.And weavingthroughitall,likeagoldenthread,istheabsolute necessityforrobustdatamanagement.“Robustdata managementandintegrityprotocols,”theconsortiumstates, “areessentialforthesuccessofGLUCARE,relyingon collaborationandseamlessdataintegrationateverystage.” Everydatapoint,frompreclinicalanimalmodelstudiesto theeventualhumantrials,mustbepristine.TheGLUCARE projectisn’tjustaboutabetterdevice;it’satestamentto howcriticalunimpeachabledataistomedical breakthroughs.

TheNextFrontier:PersonalizedMedicine’sData Imperative

IfGLUCAREoffersasnapshotofcurrentinnovation, MortenOlesenandCIMSarealsolookingfurtherahead, towardsafuturedominatedbypersonalizedmedicine.The oldmodelof“one-size-fits-all”drugdiscoveryis,frankly, runningoutofsteam.“Thepharmaceuticalindustryfaces significantchallengesastraditionaldrugdiscoverypipelines aredryingout,”Olesenobserves.Theanswer,heandmany othersbelieve,liesintailoringtreatmentstotheindividual.

Antibodiesareleadingthischarge,theirspecificitymaking themidealcandidatesfortherapiesdesignedarounda patient’suniquebiologicalmakeup.Buttrue personalizationdemandsmorethanjustatargeteddrug.It requiresreal-timemonitoringofahostofpatientparameters –bloodpressure,glucose,andbeyond–andtheabilityto adjusttreatmentsonthefly.Imagineaworldwhereyour medicationisn’tafixeddosetakenatfixedintervals,buta dynamicresponsetoyourbody’sever-changing state.

Thisiswherethevisionbecomestruly transformative.Connectedmonitoringdevices talkingseamlesslytomedicationadministration devices.AI-drivenalgorithmscontinuously learningandoptimizingtreatment,minimizing thosedreadedadversedrugreactions(ADRs)that canderaileventhemostpromisingtherapies. Considerdiabetesagain:areal-timeglucose monitordirectlyinstructinganinsulinpump, maintainingperfectequilibrium,preventingthe dangerouspeaksandtroughsofbloodsugar

Thelinchpinforthisentirevision?Youguessedit: dataintegrity.“Continuousandaccurate measurementofpatientparametersisessential,” Olesenstresses.Withoutit,thepromiseof personalizedmedicineremainsjustthat–a promise.

Thechallengesareimmense,ofcourse.Developing reliable,non-invasive(orlong-termimplantable) monitoringdevicesisaHerculeantask.Thehuman immunesystem,evervigilant,tendstoencapsulate implants,dullingtheirsensitivity–aproblemthat oftenrearsitsheadwithintendays.Integrating thesedeviceswithadministrationsystems, developingthesophisticatedAI,ensuring cybersecurity–thelistislong.

Yet,thisispreciselythefrontierwherecompanies likeCIMS,withtheirdeepexpertiseindata managementandtheirphilosophicalcommitment tostarting“wheretheclientis,”become indispensable.TheircollaborationwithSafe ImplantTechnologyontheGLUCAREprojectis morethanjustasingleventure;it’safoundational steptowardsthisbroadervisionofconnected,datadriven,personalizedhealthcare.

Thejourneyfromasingledatapointtoalifesavingtherapyisfraughtwithcomplexity.Butby focusingontheimmutabletruthencodedwithin thatdata,bymeticulouslyensuringitsintegrity frominceptiontoapplication,MortenOlesenand CIMSarenotjustmanaginginformation.Theyare helpingtobuildafuturewheremedicineissafer, moreeffective,andultimately,morehuman.Inthe relentlesspursuitofhealth,itturnsoutthatthe mostpowerfultoolmightjustbetheunwavering commitmenttogettingthestoryright,onedata pointatatime.

DON’T MISS AN ISSUE

www.globalhealthcaremagazine.com

Turn static files into dynamic content formats.

Create a flipbook